Kenya’s GM cassava plant gets greenlight

It's resistant to a disease that can wipe out a farmer’s entire crop.
Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox

A genetically modified (GM) cassava plant is a step closer to commercial release in Kenya, where it could help farmers overcome a crop-destroying viral disease.

If it is approved, the Kenyan scientists who developed it plan to make the seeds available for free to small farmers.

An important plant: Cassava, also called yuca, is an extremely versatile root vegetable — it can be mashed, fried, baked, or even dried and ground into a flour for bread. It’s not hugely popular in the U.S., but it plays a major role in Kenya’s economy and food supply.

“It is a very important food security crop in Kenya,” agricultural scientist Simon Gichuki, who helped develop the GM cassava, said in 2020. “In some of our counties, it is the staple crop. And when our maize reserves expire, our farmers turn to cassava to fill that gap.”

The challenge: Cassava brown streak disease (CBSD) is a viral disease transmitted by whiteflies or cuttings shared between farms. Infections render plants inedible, even for animal consumption, and can wipe out 100% of a farmer’s crop.

“In recent years, CBSD has become an epidemic.”

Simon Gichuki

While CBSD can be found across the globe, it’s had a particularly devastating impact in East Africa and Kenya, constantly undermining crop yields and threatening food security.

“In recent years, CBSD has become an epidemic,” Gichuki said, “and is currently very serious in our coastal region and western Kenya.”

The GM cassava plant: To address this, the Kenya Agricultural and Livestock Research Organization (KALRO) developed a GM cassava plant that is resistant to the CBSD virus.

“A part of the DNA of the virus is integrated into [the] plant genome,” Catherine Taracha, director of KALRO’s Biotechnology Centre, explained. ”The plant defenses are activated to recognize, target, and degrade the virus pathogen.”

The group spent five years growing and refining the plants in the lab and in confined field trials. Based on those experiments, Kenyan authorities determined that the GM cassava plant was just as safe as the non-GM version for humans, animals, and the environment.

Looking ahead: The authorities have now given KALRO the greenlight to conduct national performance trials, during which the plant will be grown in open fields at sites across the nation. 

After two years, KALRO will submit a report on the trials to authorities, who can then decide whether or not the GM cassava plant should be made available to farmers and ultimately sold to consumers. 

If granted that approval, KALRO plans to provide the seeds to small farmers for free.

“I believe all cassava farmers and consumers like me are looking forward to the day when these CBSD resistant cassava varieties will be cultivated in our farms,” Gichuki said.

We’d love to hear from you! If you have a comment about this article or if you have a tip for a future Freethink story, please email us at [email protected].

Sign up for the Freethink Weekly newsletter!
A collection of our favorite stories straight to your inbox
Related
The West needs more water. This Nobel winner may have the answer.
Paul Migrom has an Emmy, a Nobel, and a successful company. There’s one more big problem on the to-do list.
This $400 genetic test could save your life
Nucleus Genomics’ new whole genome sequencing and analysis service promises to reveal the secrets hidden in your DNA.
Boosted Breeding and beyond: 3 tech trends that could end world hunger
A world without hunger is possible, and the development and deployment of new farming technologies could be one key to manifesting it.
Plant sensors could act as an early warning system for farmers
Using sensors made from carbon nanotubes, researchers discovered signals that help plants respond to stresses like heat, light, or attack.
New study challenges long-held assumption about cancer
Genetic mutations may not be necessary for cancer to develop, challenging a long-held assumption about the disease.
Up Next
hearing loss
Subscribe to Freethink for more great stories